- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05326529
Comparison of Traditional, Web-based or a Combined Cardiac Rehabilitation Programme
To Examine the Effectiveness of Physical Activity, Quality of Life and Hospital Anxiety and Depression Outcomes in Cardiovascular Patients Using Either Traditional, Web-based or a Combined Cardiac Rehabilitation Programme.
The study explores the different modes of Cardiac Rehabilitation delivery including the use of a web-based programme. Cardiac Rehabilitation provides a structured, comprehensive programme, proven to reduce cardiovascular mortality and improve overall Quality of Life. However, as uptake remains relatively low with only 50% attending, exploring the benefits of offering a menu of programme options may allow greater patient choice and accessibility, meeting individual needs.
This study aims to compare how effective Cardiac Rehabilitation Programmes are on improving cardiovascular patients physical and mental wellbeing using a web-based compared with traditional cardiac rehab programmes in the hospital or through a combination of both.
Study Overview
Status
Conditions
Detailed Description
This 8-week study, aims to compare quality of life (QOL), hospital anxiety and depression scores (HADs) and physical activity outcomes in web-based Cardiac Rehabilitation (CR), web-based CR combined with traditional CR (TCR) and TCR in patients with coronary heart disease (CHD).
The Web-based option will include the use of the MyHeart application.
Participants eligible for the study will include low-moderate cardiovascular patients (heart attack, stents or heart surgery) within 3-6 weeks post discharge. Participants will be involved in hospital or virtual exercise and educational sessions with the support of CR specialists. Primary outcomes will be measured through questionnaires and an incremental treadmill walking test.
To our knowledge, this would be the first study to compare all three groups, as combined CR (web-based alongside traditional CR) has not yet been evaluated. Additionally, the investigators currently work within the CR setting at Burton Hospital, and this study will be conducted within our current Hospital CR service. The outcomes will be applicable and relevant to future clinical practice.
As the UK's 50% uptake to CR remains poor, falling below the 85% national uptake recommendations, a CR menu-based approach, offering hospital or home-based programmes is recommended to encourage uptake, improve QOL and clinical outcomes.
Furthermore, as COVID-19 has enforced a web-based CR approach, further research to explore uptake, physical and psychological outcomes to benefit cardiovascular patients is paramount for current and future CR delivery.
This study will explore a menu of options recommended for CR.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Staffordshire
-
Burton Upon Trent, Staffordshire, United Kingdom, DE13 0RB
- University of Derby and Burton NHS Foundation Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Low-moderate risk patients (low-mod Ejection Fraction (EF) (>40%), including clinically stable Myocardial Infarction (MI), Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafts (CABG) patients.
- Acute patients, in-hospital patients (phase 3 rehab) to reflect true clinical representation.
- Combination of male and female, as previous studies are predominately male.
- Low-moderate Anxiety and depression scores (<11)
- Achieve Level 4 (180metres, 5.1METs) on the Incremental Shuttle Walking Test
- Internet and device access.
Exclusion Criteria:
- <40% EF
- High risk Heart Failure patients
- Co-morbidities preventing exercise
- No internet access
- Unstable angina
- Language barrier (English only, due to app)
- Clinically depressed anxiety or depression scores (>11)
- Incremental Shuttle Walk Test <Level 4 (180metres, 5.1METs)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Traditional Cardiac Rehabilitation (Hospital based programme)
Traditional Cardiac Rehabilitation will involve 8 hospital-based exercise sessions, and one virtual education day over 8 weeks, supervised by CR health care professionals.
|
Participants will attend 8 Hospital based CR exercise sessions.
QOL and Hospital anxiety and Depression scores through questionnaires and incremental Shuttle Walk tests will be carried out pre and post intervention.
|
|
Experimental: Traditional combined with Web-based Cardiac Rehabilitation
Traditional combined with Web-based Cardiac Rehabilitation.
Patients will attend 8 hospital-based exercise sessions and one virtual education day over 8-weeks with access to additional web-based (MyHeart app) exercise and educational information.
|
Participants will attend 8 Hospital based CR exercise sessions.
QOL and Hospital anxiety and Depression scores through questionnaires and incremental Shuttle Walk tests will be carried out pre and post intervention.
Participants will complete 8 weeks of Web-based CR exercise sessions using the MyHeart app.
QOL and Hospital anxiety and Depression scores through questionnaires and incremental Shuttle Walk tests will be carried out pre and post intervention.
|
|
Experimental: Web-based Cardiac Rehabilitation
Web-based Cardiac Rehabilitation, using MyHeart app introduced during a pre-CR assessment, will follow an 8-week individualised self-managed platform, allowing contact with the CR health professionals via app messages only (no direct contact for web-based CR).
|
Participants will complete 8 weeks of Web-based CR exercise sessions using the MyHeart app.
QOL and Hospital anxiety and Depression scores through questionnaires and incremental Shuttle Walk tests will be carried out pre and post intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Baseline Energy Expenditure (Measured in METs Using the BACPR Conversion Chart) and After 8 Weeks of Intervention.
Time Frame: The Walk Test will be completed pre and post intervention (8 weeks apart)
|
An Incremental Shuttle Walk test will be performed to determine the Metabolic equivalent achieved at each level.
Metabolic Equivalent (1 MET) is defined as the amount of energy required to serve the body's energy needs.
This will range from 1 METs = lowest energy requirement to 10.9 METs highest energy requirement for completing the test.
Walking at a slower pace requires a lower level of energy expenditure and is therefore considered a light-intensity activity, walking at a faster pace requires a higher energy expenditure and is therefore considered a higher-intensity activity.
The higher the score the better the outcome for the participant as they are able to work at a higher level of exercise and thus an increase functional capacity which equates to a reduction in risk of mortality.
|
The Walk Test will be completed pre and post intervention (8 weeks apart)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychological Outcome - Hospital Anxiety and Depression Score Pre and Post Intervention
Time Frame: Questionnaires will be given to the patient to complete pre and post intervention. (8 weeks apart)
|
This will be evaluated through participants completing a Hospital Anxiety and Depression questionnaire.
Scoring range: 0-7 = normal range, 8-10 = borderline abnormal,11-21 abnormal and treatment is indicated.
The questionnaire comprises of 7 questions for Anxiety and 7 for Depression with a total score for each ranging from 1-21.
The scores will be reported separately for Anxiety and depression.
The higher the score the worse the outcome for the participant as this indicates a higher level of either anxiety or depression.
|
Questionnaires will be given to the patient to complete pre and post intervention. (8 weeks apart)
|
|
Psychological Status at Baseline (Using the Dartmouth Coop Questionnaire) and After 8 Weeks of Intervention.
Time Frame: Questionnaires will be given to the patient to complete pre and post intervention. (8 weeks apart)
|
This will be evaluated through participants completing a questionnaire consisting of questions measuring health status, physical fitness, feelings, daily activities, social activities, change in health status, current overall health perceptions and bodily pain.
Each question gives 5 response options, 1= very good, 2= good, 3= Moderate, 4=Bad, 5= Very Bad.
Minimum score = 9, maximum score 45.
Total score gives a profile of health status i.e, higher total score = poor health status.
The scores will be evaluated at baseline and after 8 weeks of intervention.
The score should be lower after 8 weeks to a reflect an improvement in overall health status.
|
Questionnaires will be given to the patient to complete pre and post intervention. (8 weeks apart)
|
|
Heart Rate Walking Speed Index at Baseline and After 8 Weeks of Intervention
Time Frame: The Walk Test will be completed pre and post intervention (8 weeks apart)
|
An Incremental Shuttle Walk test will be performed to evaluate functional capacity and determine what percentage of predicted heart rate the participant has achieved at each level of the walk test.
The maximum Heart Rate achieved at the end of the walk test will then be converted to walking speed index (HRWSI).
This will be converted using the BACPR HRWSI table which looks at the number of heart beats for every 10 meters walked when completing a standardised walking test.
HRWSI is calculated by dividing Heart rate by the walking speed (meters per minute) multiplied by 10 to give heart beats per minute walked.
Possible score ranges are 3-90 (heart beats per 10 meters).
If heart rate has decreased at any given point of the walking test compared with the baseline test, this represents an increase in aerobic fitness.
|
The Walk Test will be completed pre and post intervention (8 weeks apart)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Mike Morris, University of Chester
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 290193
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Hospital Based Cardiac Rehabilitation Exercise Classes
-
Maxima Medical CenterCompletedMyocardial Infarction | Acute Coronary SyndromeNetherlands
-
Azienda Ospedaliero Universitaria di SassariCompletedHeart Failure | Cardiac RehabilitationItaly
-
Federico II UniversityCompletedAcute Myocardial InfarctionItaly
-
Universidade do PortoCentro Hospitalar de Vila Nova de Gaia/Espinho; Research Center in Physical...CompletedCoronary Artery DiseasePortugal
-
Universidade Estadual Paulista Júlio de Mesquita...CompletedCardiovascular Diseases | Cardiovascular Risk FactorBrazil
-
Universidade Estadual Paulista Júlio de Mesquita...CompletedCardiovascular Diseases | Cardiac Risk FactorsBrazil
-
Sahlgrenska University Hospital, SwedenUppsala University; Göteborg University; Linkoeping UniversityRecruiting
-
Kutahya Health Sciences UniversityCompletedCoronary Artery Disease | Coronary Heart DiseaseTurkey (Türkiye)
-
University of UlsterBelfast Health and Social Care Trust; South Eastern Health and Social Care...CompletedMyocardial Infarction | Myocardial Ischemia | Coronary Artery Disease | Coronary ArteriosclerosisUnited Kingdom
-
Chang Gung Memorial HospitalRecruitingHeart Failure; With DecompensationTaiwan